Guidance

JCVI interim position statement on the use of Bexsero meningococcal B vaccine in the UK

An interim position statement about the use of Bexsero meningococcal B vaccine in the UK released by JCVI.

Detail

The Joint Committee on Vaccination and Immunisation (JCVI) interim position statement sets out the outcome of the considerations of JCVI and its meningococcal sub-committee on the use of meningococcal B vaccine, Bexsero in the UK. JCVI is seeking comments from stakeholders who provided evidence to JCVI and its sub-committee before finalising its position statement.

Help us improve GOV.UK

Please don't include any personal or financial information, for example your National Insurance or credit card numbers.